Sci-Tech Seattle: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Seattle.

Press releases published on June 5, 2026

Jun. 5, 2026

Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease

Indeterminate GlobeNewswire

Jun. 5, 2026

CareCloud Shareholders Overwhelmingly Approve All Proposals, Reaffirming Confidence in Company Leadership and Strategy

Indeterminate GlobeNewswire

Jun. 5, 2026

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

FDA Confirms CardiAMP HF II May Support Premarket Approval of CardiAMP Cell Therapy for Ischemic HFrEF

Indeterminate GlobeNewswire

Jun. 5, 2026

Genius Group Publishes White Paper and Investor Presentation on AI Treasury

Indeterminate GlobeNewswire

Jun. 5, 2026

Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar

Indeterminate GlobeNewswire

Jun. 5, 2026

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

BlockchAIn Announces Pricing of $55 Million Public Offering of Common Stock

Indeterminate GlobeNewswire

Jun. 5, 2026

Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026

Indeterminate GlobeNewswire

Jun. 5, 2026

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

Climb Bio Presents CLYM116 Initial Phase 1 Safety Data and Translational Modeling Results at European Renal Association (ERA) Congress 2026 Supporting Continued Development

Indeterminate GlobeNewswire

Jun. 5, 2026

Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cash Runway Well Into the First Quarter of 2027

Indeterminate GlobeNewswire

Jun. 5, 2026

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 5, 2026

SEALSQ Establishes Pure Play Quantum Platform Through Strategic Acquisitions and Investments Across Leading Quantum Computing Companies

Indeterminate GlobeNewswire

Jun. 5, 2026

BOSS Zhipin's Ongoing Share Repurchases Reach Over RMB1.67 Billion in 2026

Indeterminate GlobeNewswire

Jun. 5, 2026

Gumitide Gummies [URGENT REPORT 2026] Gumitide Shocking Boom Why Everyone Is Talking About This Weight Loss Gummies

Indeterminate GlobeNewswire

Jun. 5, 2026

7th Generation Robot Barista Surpasses Human Competitor in Shanghai Hongqiao Robot Coffee Competition

Indeterminate GlobeNewswire

Jun. 5, 2026

Here Announces Unaudited Financial Results for the Third Quarter of Fiscal Year 2026

Indeterminate GlobeNewswire

Jun. 5, 2026

EVE Energy and Stark Future Deepen Strategic Partnership to Push Electric Motorcycle Performance Further

Indeterminate GlobeNewswire

Jun. 5, 2026

Chiesi Global Rare Diseases Announces European Commission Approval of LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolaemia (HoFH)

Indeterminate GlobeNewswire